Nivolumab Improves Sorafenib-Treated Liver Cancer Nivolumab Improves Sorafenib-Treated Liver Cancer

Nivolumab immunotherapy could provide a durable response, and increase survival, for patients with advanced hepatocellular carcinoma who do not respond completely to sorafenib, new research shows.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Gastroenterology News Source Type: news